TrakCel forms strategic partnership with BarTender to integrate advanced labeling solution within its second-generation cellular orchestration platform

TrakCel forms strategic partnership with BarTender to integrate advanced labeling solution within its second-generation cellular orchestration platform

Integration provides critical label management for cell and gene therapy value chain

Cardiff, UK May 24, 2021 - TrakCel, the leading innovator of cellular orchestration solutions supporting the cell and gene therapy industry, today announces a license partnership with BarTender® by Seagull Scientific. TrakCel will integrate the BarTender barcode and labeling solution within OCELLOS by TrakCel, its second-generation cellular orchestration solution.

OCELLOS by TrakCel has been developed for cell and gene therapy manufacturers and is the first cellular orchestration solution powered by Salesforce and available on AppExchange. Its modular framework and powerful Integration Hub facilitate the end-to-end journeys of advanced therapies throughout clinical trial and commercial settings.

This key integration with BarTender features label reconciliation to enable healthcare providers and other participants along the patient journey to compliantly track and trace each label that is printed, automating the creation, management, and reconciliation of labels.

The integration of BarTender will support the current push for label standardization across the cell and gene therapy industry. The Standards Coordinating Body (SCB), a public-private partnership for coordinating, prioritizing, and supporting standards that advance process, measurement, and analytical techniques supporting the global availability of products across the cell and gene therapy industry, has identified advanced therapy labeling as a specific issue of concern. TrakCel is a contributing member of the SCB and also works in close coordination with the Alliance for Regenerative Medicine (ARM). TrakCel’s dedication to the cell and gene therapy industry and its push for standardization fueled the decision to partner with BarTender. This partnership will ensure that TrakCel provides a commercially available, industry standard solution designed to facilitate and meet international regulatory labeling standards. 

“TrakCel is building a digital ecosystem of aligned partners that will provide critical functionality to the cell and gene therapy industry through our powerful Integration Hub. Our partner ecosystem is designed to connect OCELLOS by TrakCel with leading complementary service and technology partners as part of our drive towards industry standardization,” said Chris Came, VP Global Alliances and Client Services, TrakCel. “We selected BarTender because it is a product already widely used and established within the industry and provides a powerful labeling solution that can be easily configured to meet the needs of our clients. OCELLOS by TrakCel will be the first cellular orchestration solution to provide true label reconciliation using industry standard software, eliminating reliance on the generation of PDF’s for label creation and management.”

“The cell and gene therapy industry continues experiencing exponential growth. As a fresh group of therapies moves towards commercialization, the supply ecosystem becomes more extensive. As a result, labeling standards have become critical to reduce risks, as specified by SCB and other organizations,” said Katrina Cole, General Manager EMEA, Seagull Scientific, Inc. “BarTender will provide a vital component to OCELLOS by TrakCel to ensure the safety of patients, developers and all those within the value chain.”

About TrakCel
TrakCel is the leading innovator of integrated technologies specifically created in 2012 to manage the international autologous and allogeneic cell, gene and immunotherapy supply chain. TrakCel's software platform has been developed in collaboration with, and increasingly adopted by leading companies in the cell, gene and immunotherapy industries. TrakCel’s solutions deliver real-time control over the entire therapeutic supply chain, from sample collection through manufacturing to treatment delivery. The TrakCel platform accelerates global scale-up and scale-out of cell and gene therapy products, increasing efficiency and decreasing complexity, while maintaining treatment collection to administration compliance and traceability.  TrakCel is headquartered in Cardiff, Wales, UK with US offices in California and New Jersey. 
https://trakcel.com

About BarTender
BarTender® software by Seagull Scientific enables organizations to improve safety, security, efficiency and compliance by creating and automating labels, barcodes, RFID tags and more. Hundreds of thousands of companies in the life sciences, manufacturing, chemicals, food and beverage and other industries trust BarTender with the labeling and marking processes that keep their businesses running. With offices in North America, Europe and Asia, BarTender is available through a global network of local partners. www.seagullscientific.com.